Skip to content

Analgesic Range and Effect Evaluation of Ultrasound-Guided Erector Spinae Block on Enhanced Recovery After Surgery for Colon Cancer

Analgesic Range and Effect Evaluation of Ultrasound-Guided Erector Spinae Block on Enhanced Recovery After Surgery for Colon Cancer: a Single-Center, Prospective, Randomized, Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031255
Enrollment
Unknown
Registered
2020-03-26
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

experimental group:Under ultrasonic guidance, 20mL 0.25% ropivacaine was injected into the deep surface of T7 transverse process horizontal erector spine muscle:
control group:Under ultrasonic guidance, 20mL saline was injected into the deep surface of T7 transverse process horizontal erector spine muscle

Sponsors

Medical ethics committee of Affiliated Nanhai Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 75 years; ASA class for I- II; NYHA class I - II; Laparoscopic radical operation of colon cancer; The patient or family member signs the informed consent.

Exclusion criteria

Exclusion criteria: Abnormal coagulation function; Severe heart and lung disease, liver and kidney dysfunction; Allergic to local anesthetic drugs or opioids; Preoperative chemoradiotherapy; Inability to cooperate or communicate with difficulty; Chronic pain or a long history of mental illness; Serious complications resulted in prolonged hospital stay.

Design outcomes

Primary

MeasureTime frame
VAS;BCS;Total postoperative analgesic consumption of ketoroic acid;Thermesthesia;algesia;Hemodynamic index;

Secondary

MeasureTime frame
Gastrointestinal recovery index;Intraoperative dosage of propofol and remifentanil;

Countries

China

Contacts

Public ContactMo Ping

Medical Ethics Committee of Affiliated Nanhai Hospital of Southern Medical University

pop_pan@126.com+86 13928665645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026